Abstract
The ability of grifolan (GRN), a purified fungal (1→3)-β-D-glucan, to induce various cytokines from macrophages was examined in vitro. Interleukin-6 (IL-6) activity in supernatants from the culture of macrophage cell line, RAW264.7 was dependent on increasing doses of GRN. The level of IL-6 induced with 500μg/ml of GRN was comparable to that induced with lipopolysaccharide (LPS) 10μg/ml. Enhancement of the mRNA level of IL-6 by treatment with GRN was detected by reverse transcriptase-polymerase chain reaction (RT-PCR). The effect of GRN on production of IL-6 was also observed using peritoneal macrophages from C3H/HeJ mice which did not respond to endotoxins. This data suggested that the ability of GRN to activate IL-6 production of macrophages is not due to contamination of endotoxins in the preparation. Enhanced production of cytokine by GRN was observed not only with IL-6, but also with interleukin-1 (IL-1) and tumor necrosis factor α (TNFα). In the production of TNFα, GRN was more effective than LPS used in this study. Other soluble or gel-forming (1→3)-β-D-glucans from various sources did not enhance the production of such cytokines although they are structurally similar to GRN. The above results indicated that GRN is a novel macrophage activator which augments cytokine production without dependence on endotoxins.
